National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

Antimicrobial Agents and Chemotherapy
Po-Yu LiuPo-Ren Hsueh

Abstract

A multicenter collection of bacteremic isolates of Escherichia coli (n = 423), Klebsiella pneumoniae (n = 372), Pseudomonas aeruginosa (n = 300), and Acinetobacter baumannii complex (n = 199) was analyzed for susceptibility. Xpert Carba-R assay and sequencing for mcr genes were performed for carbapenem- or colistin-resistant isolates. Nineteen (67.8%) carbapenem-resistant K. pneumoniae (n = 28) and one (20%) carbapenem-resistant E. coli (n = 5) isolate harbored bla KPC (n = 17), bla OXA-48 (n = 2), and bla VIM (n = 1) genes.

References

Nov 1, 1989·Antimicrobial Agents and Chemotherapy·J E McGowanP L Parrott
Oct 30, 1999·Antimicrobial Agents and Chemotherapy·J GarauA Ruíz-Bremón
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Conan MacDougallRonald E Polk
Jan 29, 2008·The Journal of Antimicrobial Chemotherapy·Lee H NguyenAnnie Wong-Beringer
Nov 18, 2010·The Journal of Antimicrobial Chemotherapy·Benjamin A RogersDavid L Paterson
Dec 7, 2010·The Journal of Antimicrobial Chemotherapy·Yan QiYunsong Yu
Nov 8, 2011·International Journal of Antimicrobial Agents·Gunnar Kahlmeter, Hanna Odén Poulsen
May 9, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Hui-Hsiu WuYuarn-Jang Lee
Aug 25, 2016·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yuan-Chih MaoChao-Tai Lee
Sep 9, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Sabine Bou-AntounRussell J Hope
Nov 9, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Wil NgKevin Katz
Nov 21, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Young Ah KimKyungwon Lee
Jan 17, 2017·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chin-Shiang TsaiWen-Chien Ko
Aug 23, 2017·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chang-Hua ChenMing-Li Liou
Sep 21, 2017·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Wan-Lin TsaiMing-Fang Cheng
Dec 26, 2017·The Lancet Infectious Diseases·Evelina TacconelliUNKNOWN WHO Pathogens Priority List Working Group
Feb 15, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Ana Rita RebeloRene S Hendriksen
Jun 11, 2018·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Shu-Chen KuoShang-Chwen Chang
Apr 18, 2019·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A RojasJ Rodríguez-Baño
Apr 24, 2019·Antimicrobial Agents and Chemotherapy·Daniel J DiekemaRonald N Jones
Apr 30, 2019·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Sarunyou ChusriYohei Doi
Oct 20, 2019·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Wei FengFengjun Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.